ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,607, issued on May 27, was assigned to Avitide LLC (Lebanon, N.H.).
"AAV9 affinity agents" was invented by William Scott Dodson (Lebanon, N.H.), Brandon Kier (Lebanon, N.H.), Brandon Coyle (Lebanon, N.H.), Sarah Valentini (Lebanon, N.H.), Thomas Scanlon (Lebanon, N.H.) and Warren Kett (Lebanon, N.H.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are affinity agents comprising ligands that specifically bind adeno-associated virus. The affinity agents are useful for binding, isolation, and/or purification of adeno-associated virus. Further disclosed are amino acid sequences of binding motifs or polypeptides comprised by the ligands, an...